Infect Immun 2000, 68:2053–2060.PubMedCrossRef 53. Rennermalm A, Nilsson M, Flock J-I: The fibrinogen Binding Protein Of S. epidermidis is a Target for Opsonic Antibodies. Infect Immun 2004, 72:3081–3083.PubMedCrossRef 54. Weisman LE, Fischer GW, Thackray HM, Johnson KE, Schuman RF, Mandy GT, Stratton BE, Adams KM, Kramer C59 wnt purchase WG, Mond JJ: Safety and pharmacokinetics of a chimerized anti-lipoteichoic acid monoclonal antibody in healthy adults. Int Immunopharmacol 2009, 9:639–644.PubMedCrossRef 55. Broekhuizen CA, de Boer L, Schipper K, Jones CD, Quadir S, Feldman RG, Vandenbroucke-Grauls
CM, Zaat SA: The influence of antibodies on Staphylococcus epidermidis adherence to polyvinylpyrrolidone-coated silicone elastomer in experimental biomaterial-associated infection in mice. Biomaterials 2009, 30:6444–6450.PubMedCrossRef 56. Harro JM, Peters BM, O’May GA, Archer N, Kerns P, Prabhakara R, Shirtliff ME: Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration. FEMS Immunol Med Microbiol 2010, 59:306–323.PubMed 57. McKenney D, Pouliot KL, Wang Y, Murthy V, Ulrich M, Döring MK-8776 supplier G, Lee JC, Goldmann DA, Pier GB: Broadly protective vaccine for Staphylococcus
aureus based on an in vivo expressed antigen. Science 1999, 284:1523–1527.PubMedCrossRef 58. MEK162 nmr Maira-Litran T, Kropec A, Goldmann DA, Pier GB: Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated staphylococcal poly-N-acetyl-beta-(1–6)-glucosamine. Infect Immun 2005, 73:6752–6762.PubMedCrossRef 59. Perez MM, Prenafeta A, Valle J, Penadés J, Rota C, Solano C, Marco J, Grilló MJ, Lasa I, Irache JM, Maira-Litran T, Jiménez-Barbero J, Costa L, Pier GB, de Andrés D, Amorena B: Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl beta-1,6 glucosamine specific antibody production using biofilm-embedded bacteria. Vaccine 2009, 27:2379–2386.PubMedCrossRef 60. Gening M, Maira-Litran T, Kropec A, Skurnik
D, Grout M, Tsvetkov YE, Nifantiev NE, Pier GB: Synthetic beta-(1,6)-linked N-acetylated and non-acetylated ioxilan oligoglucosamines to produce conjugate vaccines for bacterial pathogens. Infect Immun 2010, 78:764–772.PubMedCrossRef 61. Spellberg B, Daum R: A new view on development of a Staphylococcus aureus vaccine. Hum Vaccin 2010, 6:857–859.PubMedCrossRef 62. Ohlsen K, Lorenz U: Immunotherapeutic strategies to combat staphylococcal infections. Int J Med Microbiol 2010, 300:402–410.PubMedCrossRef 63. Mack D, Rohde H, Dobinsky S, Riedewald J, Nedelmann M, Knobloch JK-M, Elsner H-A, Feucht HH: Identification of three essential regulatory gene loci governing expression of the Staphylococcus epidermidis polysaccharide intercellular adhesion and biofilm formation. Infect Immun 2000, 68:3799–3807.PubMedCrossRef 64.